Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
- Friday, October 14, 2022, 7:14
- PR Newswire
- Add a comment
NORWOOD, Mass., Oct. 14, 2022 /PRNewswire/ — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an immunology company, today announced a poster presentation at the SITC 2022 Annual Meeting being held November 8-12, 2022. The poster will share the updated…
About the Author
admin has written 20663 stories on this site.